CEO Corner

CEO Corner articles are written by presidents or CEOs of biopharmaceutical or medical device companies that create a drug or device. These articles discuss global industry trends, experiences, and challenges that biopharma CEOs and presidents can relate to and should be aware of.  

  • Collaborating To Stem The Tide Of Emerging Antimicrobial Resistance
    Collaborating To Stem The Tide Of Emerging Antimicrobial Resistance

    Jeffrey Stein, Ph.D., president and CEO of Cidara Therapeutics, discusses what needs to be done now by drug companies and healthcare providers alike to stem the tide of emerging antimicrobial resistance, including collaboration to address market barriers.

  • The Biotech CEO — It’s Not For Everyone
    The Biotech CEO — It’s Not For Everyone

    I’ve often described the challenge of developing new medicines as analogous to the difficulty of climbing the highest mountains on Earth. If one follows that analogy, then seeking to develop a new treatment for Alzheimer’s disease is like climbing K2, the second highest peak — in winter. That feat has not yet been accomplished, and those who aspire to do so describe it as their last frontier. Similarly, the brain is one of the last frontiers in medicine and drug development.

  • The Case For A Healthcare Futures Market
    The Case For A Healthcare Futures Market

    Now is the time to develop a novel financial instrument which will provide risk transfer, transparency, and more certainty. A futures market in healthcare is a product whose time has come.

  • Understanding The Many Faces Of Innovation
    Understanding The Many Faces Of Innovation

    By its very definition, innovation may travel long and painful paths, require repeated failure, and invite numerous mistakes to gather experience for bringing forward something new. Lady luck also intervenes occasionally, as well.

  • Why More Incentives Are Needed To Tackle Antibiotic Resistance
    Why More Incentives Are Needed To Tackle Antibiotic Resistance

    Antibiotic resistance is a real and immediate threat that is beginning to garner the global attention it needs and deserves. During a meeting of the United Nations in September 2016, the entire General Assembly — 193 nations — reaffirmed its commitment to developing national action plans on combatting antibiotic resistance.

  • An Insider’s View Of Life Outside The Academic Gilded Cage
    An Insider’s View Of Life Outside The Academic Gilded Cage

    There is a lyric from an old Bob Seger song in which the aging songwriter, lamenting the loss of his youthful prowess once filled with vim and vigor, wonders where the time went (“20 years now; where’d they go; 20 years; I don’t know”).

  • Can Financial Markets Solve The Ever-Increasing Costs of Healthcare?
    Can Financial Markets Solve The Ever-Increasing Costs of Healthcare?

    Why hasn't the healthcare industry evolved into vertical segmentation like other industries? Until now, it's because there has been no systematic way to hedge/transfer either institutional or operating risk in the healthcare system because information gathering and delivery is generally limited and poorly organized.

  • Biotechnology: The Hope For Rare Diseases
    Biotechnology: The Hope For Rare Diseases

    John Crowley, chairman and CEO of Amicus Therapeutics discusses why biotechs in the rare disease space face particularly unique and fundamental challenges.

  • Drug Company Discovery & Commercialization: An Election Year Analogy
    Drug Company Discovery & Commercialization: An Election Year Analogy

    As I consider the move from clinical to commercialization, it reminds me of the American electoral system – primary elections that are tightly focused and a general election where a candidate faces a vastly broader audience and has the opportunity to engage on a much larger stage and with far greater impact.

  • The Constant Search For More Efficient Paths To Approval
    The Constant Search For More Efficient Paths To Approval

    There are several general principles that can help accelerate clinical development, beginning and ending with a focus on getting the drug to the patients that need it.

More From CEO Corner

LIFE SCIENCE EVENTS

CAPA and Root Cause Analysis Essentials Post ICH GCP E6 (R2) Addendum August 21, 2017
11:00am- 12:00pm EDT, Online Training
Duration:  60 Minutes
Price:  $299 - Includes Bonus Handouts!
Outsourced Pharma August 22 - 23, 2017
San Diego, CA
How To Establish The Number of Runs Required For Process Validation August 23, 2017
1:00 - 2:00 PM EDT, Online Training
Duration:  60 Minutes
Price:  $299 - Includes Bonus Handouts!
Monitoring Plan Development: Post ICH GCP E6 (R2) Addendum August 25, 2017
11:00am- 12:00pm EDT, Online Training
Duration:  60 Minutes
Price:  $299 - Includes Bonus Handouts!
FDA GMP Inspections – Proven Preparation & Survival Techniques August 29, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Natalie James September 4, 2017
Paris
EU vs. US GMP: Understanding Major Differences Post FDA/EMA Mutual Recognition Agreement September 6, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Mobile In Clinical Trials September 6, 2017
Boston, MA
Mobile In Clinical Trials September 6, 2017
Boston, MA
Disruptive Innovations US September 7 - 8, 2017
Boston, MA
Conducting an Effective GCP Audit of a CRO-Managed Ongoing Study: Tips and Suggestions September 7, 2017
1:00 - 2:30 PM EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
Investigator Oversight Plans: Essentials for Inspection Readiness Post ICH GCP E6 (R2) Addendum September 11, 2017
11:00am- 12:00pm EDT, Online Training
Duration:  60 Minutes
Price:  $299 - Includes Bonus Handouts!
Cleanroom Microbiology – A Foundational Introduction September 12, 2017
1pm-2:30pm EDT, Online Training
Duration:  90 Minutes
Price:  $299 - Includes Bonus Handouts!
6th Annual Bacteriology and Parasitology Meeting September 13 - 14, 2017
Singapore, SC
Program Coordinator September 13 - 14, 2017
Singapore, SC
smruthi Ruth September 13 - 14, 2017
Singapore City, NV
Project Management & Execution for Pharma/Biotech Manufacturing Facilities – A Step-by-Step Guide September 14, 2017
1pm-2:30pm EDT, Online Training
Price:  $299 - Includes Bonus Handouts!
PharmaForce 2017 September 18 - 20, 2017
Austin, TX
Sara young September 20 - 22, 2017
Charlotte, NC